University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Real-world Evidence on Baseline Characteristics and Treatment in Metastatic Hormone-sensitive Prostate Cancer : Findings from the PIONEER 2.0 Big Data Investigation Group

dc.contributor.authorRivas, Juan Gómez
dc.contributor.authorKraft, Pia
dc.contributor.authorEvans-Axelsson, Susan
dc.contributor.authorHijazy, Ayman
dc.contributor.authorBeyer, Katharina
dc.contributor.authorDe Meulder, Bertrand
dc.contributor.authorLiu, Alex Qinyang
dc.contributor.authorGolozar, Asieh
dc.contributor.authorHarbachou, Artsiom
dc.contributor.authorFeng, Qi
dc.contributor.authorSnijder, Robert
dc.contributor.authorSteinbeisser, Carl
dc.contributor.authorRemmers, Sebastiaan
dc.contributor.authorGandaglia, Giorgio
dc.contributor.authorRajwa, Pawel
dc.contributor.authorKotik, Daniel
dc.contributor.authorKasivisvanathan, Veeru
dc.contributor.authorOmar, Muhammad I.
dc.contributor.authorSierra, Jesús Moreno
dc.contributor.authorBriganti, Alberto
dc.contributor.authorGacci, Mauro
dc.contributor.authorWillemse, Peter-Paul M.
dc.contributor.authorBrash, James T.
dc.contributor.authorDavies, Eleanor
dc.contributor.authorCornford, Philip
dc.contributor.authorAbbott, Thomas
dc.contributor.authorN’Dow, James
dc.contributor.authorNicoletti, Rossella
dc.contributor.authorPIONEER 2.0 Big Data Investigation Group
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Academic Urology Uniten
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Cancer Centreen
dc.date.accessioned2025-10-08T09:29:19Z
dc.date.issued2025-11
dc.descriptionPIONEER Consortium collaborator list: Laurent Antoni, Charles Auffray, Anssi Auvinen, Chris Bangma, Anders Bjartell, Gabi Bernstein, Angelika Borkowetz, Danny Burke, Michael Bussmann, John Butler, Riccardo Campi, Simona Caputova, Laurence Colette, Louise Fullwood, Ronald Herrera, Thomas Hofmarcher, Marc Holtorf, Denis Horgan, Henkjan Huisman, Tim Hulsen, Andreas Josefsson, Daniel Kotik, Mark Lambrecht, Doron Lancet, Michael Lardas, Ailbhe Lawlor, Stephane Lejeune, Sophia Le Mare, Muriel Licour, Peter Lindgren, Elaine Longden-Chapman, Monika Maass, Maxim Moinat, Lisa Moris, Nicolas Mottet, Teemu Murtola, Kishore Papineni, Sarah Payne, Christian Reich, Kristin Reiche, Maria J. Ribal, Paul Robinson, Monique J. Roobol, Beth Russell, Vasileios Sakalis, Jack Schalken, Sarah Seager, Robert Shepherd, Aino Siltari, Emma Jane Smith, Azadeh Tafreshiha, Kirsi Talala, Teuvo Tammela, Derya Tilki, Patrizia Torremante, Sheela Tripathee, Kees van Bochove, Mieke Van Hemelrijck, Tapio Visakorpi, Marc Dietrich Voss, Jihong Zong, and Nazanin Zounemat Kermani.en
dc.description.statusPeer revieweden
dc.format.extent10
dc.format.extent2662861
dc.identifier309707893
dc.identifier900f74e2-b11b-45c8-9bed-bfb060aa4373
dc.identifier105018219117
dc.identifier41127821
dc.identifier.citationRivas, J G, Kraft, P, Evans-Axelsson, S, Hijazy, A, Beyer, K, De Meulder, B, Liu, A Q, Golozar, A, Harbachou, A, Feng, Q, Snijder, R, Steinbeisser, C, Remmers, S, Gandaglia, G, Rajwa, P, Kotik, D, Kasivisvanathan, V, Omar, M I, Sierra, J M, Briganti, A, Gacci, M, Willemse, P-P M, Brash, J T, Davies, E, Cornford, P, Abbott, T, N’Dow, J, Nicoletti, R & PIONEER 2.0 Big Data Investigation Group 2025, 'Real-world Evidence on Baseline Characteristics and Treatment in Metastatic Hormone-sensitive Prostate Cancer : Findings from the PIONEER 2.0 Big Data Investigation Group', European Urology Open Science, vol. 81, pp. 82-91. https://doi.org/10.1016/j.euros.2025.09.010en
dc.identifier.doi10.1016/j.euros.2025.09.010
dc.identifier.issn2666-1683
dc.identifier.otherRIS: urn:686100CCA840CD16D64A92811B76FF13
dc.identifier.otherORCID: /0000-0001-5340-0081/work/194126117
dc.identifier.otherORCID: /0000-0002-1597-3126/work/194126159
dc.identifier.urihttps://hdl.handle.net/2164/26169
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S266616832501417Xen
dc.language.isoeng
dc.relation.ispartofEuropean Urology Open Scienceen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectAndrogen deprivation therapyen
dc.subjectAndrogen receptor pathway inhibitorsen
dc.subjectBig dataen
dc.subjectComorbiditiesen
dc.subjectChemotherapyen
dc.subjectMetastatic hormone-sensitive prostate canceren
dc.subjectPIONEER+en
dc.subjectProstate canceren
dc.subjectReal-world dataen
dc.subjectReal-world evidenceen
dc.subjectTreatmenten
dc.subjectRC0254 Neoplasms. Tumors. Oncology (including Cancer)en
dc.subject.lccRC0254en
dc.titleReal-world Evidence on Baseline Characteristics and Treatment in Metastatic Hormone-sensitive Prostate Cancer : Findings from the PIONEER 2.0 Big Data Investigation Groupen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Rivas_etal_EUOS_Real-World_Evidence_VOR.pdf
Size:
2.54 MB
Format:
Adobe Portable Document Format

Collections